2022
DOI: 10.1093/jscr/rjac452
|View full text |Cite
|
Sign up to set email alerts
|

Multifocal synchronous renal cell carcinoma of three different histologic subtypes: unusual findings and literature review

Abstract: We present a case of three multifocal synchronous ipsilateral clear cell, papillary type 1 and papillary type 2 renal cell carcinoma (RCC), with papillary type 2 RCC appearing bilaterally. With review of the literature, it was determined that multifocal synchronous RCC subtypes and bilateral renal tumors are both rare in occurrence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…Tumor cells of the papillary subtype showed a large number of eosinophilic, atypical nuclei and prominent nucleoli, whose morphology was not excluded FH-deficient RCC, but no FH protein or molecular associated detection was performed to confirm it. 18 Here, we report a patient with detailed molecular analysis. In our case, clear cell RCC (right) was more likely caused by the VHL somatic frameshift mutation, whereas FH-deficient RCC (left) was caused by the FH germline mutation.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Tumor cells of the papillary subtype showed a large number of eosinophilic, atypical nuclei and prominent nucleoli, whose morphology was not excluded FH-deficient RCC, but no FH protein or molecular associated detection was performed to confirm it. 18 Here, we report a patient with detailed molecular analysis. In our case, clear cell RCC (right) was more likely caused by the VHL somatic frameshift mutation, whereas FH-deficient RCC (left) was caused by the FH germline mutation.…”
Section: Discussionmentioning
confidence: 97%
“…Tumor cells of the papillary subtype showed a large number of eosinophilic, atypical nuclei and prominent nucleoli, whose morphology was not excluded FH-deficient RCC, but no FH protein or molecular associated detection was performed to confirm it. 18…”
Section: Discussionmentioning
confidence: 99%
“…The life expectancy of the patient with end stage renal disease must be at least 5-years after considering the co-morbidities to include in the wait list for renal subtypes [2][3][4][5]. Martha C, et al described 3 subtypes clear cell, type 1 and type 2 papillary renal cell carcinoma, but not chromophobe renal cell carcinoma [6]. Bilateral radical nephrectomy in renal failure patients who are on dialysis is not commonly done [7][8][9].…”
Section: Discussionmentioning
confidence: 99%
“…The life expectancy of the patient with end stage renal disease must be at least 5-years after considering the co-morbidities to include in the wait list for renal subtypes [2][3][4][5]. Martha C, et al described 3 subtypes clear cell, type 1 and type 2 papillary renal cell carcinoma, but not chromophobe renal cell carcinoma [6]. Bilateral radical nephrectomy in renal failure patients who are on dialysis is not commonly done [7][8][9].…”
Section: Discussionmentioning
confidence: 99%